ATS 2024 Final Program

Click on the session title to view the speakers

264

TUESDAY • MAY 21

Thrombolysis. Analysis of a National Inpatient Sample P995 Use of the Wnt/ß-catenin Activator Lithium Is Associated With Less Emphysema P996 Association Between the Cross-sectional Area of P997 Epidemiology of Osteoporosis in Patients With Chronic Obstructive Pulmonary Disease in Taiwan P998 Impact of Chronic Obstructive Pulmonary Disease on the Prognosis of Patients With Lung Cancer P999 COPD Exacerbations in Patients With Inflammatory Bowel Disease, Is There a Difference in Outcomes? P1000 Does Persistent Hypercapnia Have Worse Outcomes With Coronary Artery Disease? P1001 Risk Factors for Severe Exacerbation Occurrence Among Patients With COPD-OSA Overlap Syndrome Using Bilevel Positive Airway Pressure Therapy P1002 An Epidemiological Survey of Ugandans With COPD and Sleep Apnea P1003 Development of a Clinical Prediction Model for Fall Risk in COPD P1004 Pulmonary Comorbidities, Respiratory Symptoms, and Spirometry in a Real-world, Urban Lung Cancer Screening Program P1005 Healthcare Utilization Burden, Treatment Patterns, and Erector Spinae Muscles and Mortality in Patients With Combined Pulmonary Fibrosis and Emphysema

CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

C55 COMORBIDITIES OF COPD:

EPIDEMIOLOGY AND TREATMENT IMPLICATIONS

9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area I (Hall H, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P985 The Prognostic Impact of Comorbidity in Chronic Obstructive Pulmonary Disease Outpatients P986 The Association Between Spirometry, Chest CT Parameters, and Prevalent and Incident Atrial Fibrillation in a Tobacco-exposed Cohort P987 Characteristics of Ever-smokers With and Without Chronic Obstructive Pulmonary Disease Who Demonstrate Coronary Artery Calcium Progression P988 The Burden of Radiological Coronary Artery Disease in Chronic Obstructive Pulmonary Disease and Its Relationship to Shared Risk Factors P989 New 2022 ESC/ERS Severe Pulmonary Hypertension Definition Better Predicts Mortality in Patients With COPD P990 Association of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor Use and Chronic Obstructive Pulmonary Disease (COPD) Outcomes Amongst Patients With Type 2 Diabetes Mellitus P991 Implications of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor Use in the Incidence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) Amongst Patients With Type 2 Diabetes Mellitus P992 Evaluating the Pulmonary Impact of Semaglutide in Patients With Diabetes: A Meta-analysis of Randomized Clinical Trials P993 The Relationship Between Diabetes and Preserved Ratio Impaired Spirometry (PRISM): Findings From Nhanes 2007-2012 P994 Increased Risk of Mortality in Patients With Acute Stroke and a Diagnosis of COPD Who Underwent

Cardiopulmonary Outcomes in Patients Following Hospital Discharge for a COPD Exacerbation in a United States Administrative Database

BEHAVIORAL • CLINICAL THEMATIC POSTER SESSION

C56 NAVIGATING OCCUPATIONAL HAZARDS: CASE REPORTS IN WORK-RELATED LUNG DISEASE 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees San Diego Convention Center Area E (Hall A-B2, Ground Level)

ATS 2024 Conference Program • San Diego, CA